Title
Category
Credits
Event date
Cost
- Grand Rounds
- Mood Disorders
- 1.00 ACEP NBCC clock hours
- 1.00 AMA PRA Category 1 Credit™
- 1.00 Category I credits for Social Workers
- 1.00 Psychologists
- 1.00 MNA Contact Hours for Nurses
- 1.00 Participation
10/09/2024
$0.00
Disruptive mood dysregulation disorder (DMDD) is a condition defined by frequent explosive outbursts occurring within the context of chronic, pervasive irritability, beginning in early childhood. This lecture reviews how the condition evolved and speculates that although it originated ostensibly as a response to the overdiagnosis of bipolar disorder in children, and the overdiagnosis of bipolar disorder occurred because of the absence of a good diagnostic home for explosive outbursts. Evidence suggests depression and anxiety are outcomes of DMDD however that does not account for the outcome of the outbursts. I will also discuss briefly the relationship of other mood and behavior disorders to DMDD, assessment and treatment.
- Basic Science
- Grand Rounds
- 1.00 ACEP NBCC clock hours
- 1.00 AMA PRA Category 1 Credit™
- 1.00 Category I credits for Social Workers
- 1.00 Psychologists
- 1.00 MNA Contact Hours for Nurses
- 1.00 Participation
10/23/2024
$0.00
Access to specialty mental health care is limited for most Americans, with more than half of those having a mental illness not receiving treatment. Further, for patients who need emergent psychiatric care, rates of prolonged length of stay in Emergency Departments have increased with the onset of the COVID-19 pandemic. There is a need for innovative solutions designed to support clinicians and streamline care processes. Digital health tools (e.g., mobile apps, wearable devices, telemedicine, electronic health records) have the potential to significantly improve the delivery of health care services and care of patients. Given the rising need for mental health services, digital tools are increasingly utilized to improve capacity and augment clinical care. This workshop will discuss several innovative digital solutions designed to improve access to mental health care.
- Grand Rounds
- Psychodynamic Therapy
- 1.50 ACEP NBCC clock hours
- 1.50 AMA PRA Category 1 Credit™
- 1.50 Category I credits for Social Workers
- 1.50 Psychologists
- 1.50 MNA Contact Hours for Nurses
- 1.50 Participation
10/28/2024
$0.00
Formulation is essential to every treatment. Without a formulation, we are unable to make a diagnosis, collaboratively create a treatment plan, or engage in treatment. Yet formulation is not always taught, and, when it is, this teaching is not always clear. In this talk, Deborah Cabaniss will discuss the work that she and colleagues in the Psychodynamic Formulation Collective have done to operationalize psychodynamic formulation and to place the effects of culture and society on par with other psychodynamic models of the mind. Clinically relevant to all patient settings, this talk will be of interest to trainees and seasoned clinicians alike.
- Addiction
- Grand Rounds
- 1.00 ACEP NBCC clock hours
- 1.00 AMA PRA Category 1 Credit™
- 1.00 Category I credits for Social Workers
- 1.00 Psychologists
- 1.00 MNA Contact Hours for Nurses
- 1.00 Participation
11/20/2024
$0.00
At the turn of the 21st century, pain management became a major public health concern, recognized as the 5th vital sign in VA healthcare, while opioid prescribing for chronic pain surged, leading to a fivefold increase in morphine milligram equivalents by 2010. In 2013, the DSM-5 redefined Substance Use Disorder (SUD) criteria, excluding tolerance and withdrawal for medically prescribed opioids. As the opioid epidemic unfolded, the limitations of long-term opioid therapy for chronic pain became evident, prompting current guidelines to discourage opioid initiation in favor of non-opioid approaches. However, some patients remain on long-term opioid therapy, struggling to taper without functional improvement, raising questions about whether these cases fit under mild Opioid Use Disorder (OUD) or require a new diagnostic category. This talk will address this ambiguity, outlining a clinical decision-making framework, and exploring the need for new diagnostic approaches when opioid harms outweigh benefits.